Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
Published Nov 1, 2017 · Jared M. Campbell, Susan M. Bellman, M. Stephenson
Ageing Research Reviews
299
Citations
4
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayMetformin use may extend life and healthspans by acting as a geroprotective agent, reducing all-cause mortality and diseases of aging in diabetic patients.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.